Epigenetic therapy to enhance therapeutic effects of PD-1 inhibition in uveal melanoma
V. R. Sah, H. Jespersen, J. Karlsson, M. Lindberg, L. M. Nilsson, L. Ny, J. A. Nilsson
This study investigates enhancing PD-1 inhibitor efficacy in uveal melanoma through epigenetic modulation with HDAC or BET inhibitors, finding that HDAC inhibition synergizes with immunotherapy.
bioRxiv · Feb 4, 2021Cancer Biology